tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Global Blood Therapeutics's activity chart (see below) currently has 195 price targets and 150 ratings on display.
Analysts average stock forecasts to be materialized ratio is 54.73% with an average time for these price targets to be met of 335.58 days.
Most recent stock forecast was given by from TRUIST on 09-Aug-2022. First documented stock forecast 08-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Dec-2020
$68.5
$0.01 (0.01%)
$60
3 years 10 months 29 days ago
(09-Aug-2022)
2/5 (40%)
$1.91 (2.87%)
274
Buy Since 01-Apr-2019
$68.5
$0.01 (0.01%)
$133
3 years 10 months 29 days ago
(09-Aug-2022)
1/6 (16.67%)
$1.91 (2.87%)
567
Buy Since 14-Apr-2021
$68.5
$0.01 (0.01%)
$53
3 years 10 months 29 days ago
(09-Aug-2022)
4/5 (80%)
$1.91 (2.87%)
290
Buy Since 08-Sep-2015
$68.5
$0.01 (0.01%)
$67
3 years 10 months 29 days ago
(09-Aug-2022)
7/9 (77.78%)
$1.91 (2.87%)
825
Buy
$68.5
$0.01 (0.01%)
3 years 11 months ago
(08-Aug-2022)
0/1 (0%)
$1.9 (2.85%)
What is GBT (Global Blood Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GBT (Global Blood Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GBT (Global Blood Therapeutics)?
Which analyst is the currently most bullish on GBT (Global Blood Therapeutics)?
Which analyst is the currently most reserved on GBT (Global Blood Therapeutics)?
